We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S., EU Expand Collaboration on Drug Development, Inspections
U.S., EU Expand Collaboration on Drug Development, Inspections
The U.S. Food and Drug Administration and European Medicines Agency will establish a joint patient engagement working group to share best practices on involving patients in drug development and monitoring.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor